Recombinant-human erythropoietin and the effects oof different routes of administration L. A. M. Frenken and R. A. P. Koene

Therapy with Recombinant Human Erythropoietin (rEPO) in Hemodialysis Patients with Transfusion-Dependent Anemia. Report of a European Multicenter Trial P. Grützmacher, B. Ehmer, D. Messinger and P. Scigalla on behalf of the multicenter group

Hemostasis assessment in patients treated with recombinant human erythropoietin S. Casati and M. Moia